PHAT Debt to Equity
-0.49×TTM
Retrieved:
PHAT FY Debt/Equity
1.65×-2.29×
2018-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
PHAT debt to equity history
Debt-to-equity ratio. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.
| Period ending | Debt to Equity |
|---|---|
| -0.4834× | |
| -0.7962× | |
| -1.9108× | |
| -1.2975× | |
| 1.2659× | |
| 0.2523× | |
| 0.1034× | |
| -1.5163× |
Compare debt to equity
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) debt to equity
- Bridgebio Pharma Inc (BBIO) debt to equity
- Brightspring Health Services Inc (BTSG) debt to equity
- Madrigal Pharmaceuticals Inc (MDGL) debt to equity
- Ensign Group Inc (ENSG) debt to equity
- Glaukos Corp (GKOS) debt to equity
- Vaxcyte Inc (PCVX) debt to equity
- Krystal Biotech Inc (KRYS) debt to equity
Compare all covered stocks by debt to equity →
All PHAT financial metrics · PHAT stock overview · How to interpret financial metrics